Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?
Authors:
- Anna Sowa-StaszczakASAnna Sowa-Staszczak
- Robert ChrzanRCRobert Chrzan
- Dorota PachDPDorota Pach
- Agnieszka StefańskaASAgnieszka Stefańska
- Monika TomaszukMTMonika Tomaszuk
- Monika Buziak-BerezaMBMonika Buziak-Bereza
- Maciej KołodziejMKMaciej Kołodziej
- Elwira Przybylik-MazurekEPElwira Przybylik-Mazurek
- Alicja Hubalewska-DydejczykAHAlicja Hubalewska-Dydejczyk
- 1 July 2012
- journal article
- Published by Elsevier in Clinical Imaging
- Vol. 36 (4) , 360-364
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)European Journal of Nuclear Medicine and Molecular Imaging, 2011
- Imaging of gastroenteropancreatic neuroendocrine tumorsWorld Journal of Clinical Oncology, 2011
- Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumorLangenbeck's Archives of Surgery, 2009
- Neoadjuvant peptide receptor radionuclide therapy for aninoperable neuroendocrine pancreatic tumorWorld Journal of Gastroenterology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- The Diagnosis and Medical Management of Advanced Neuroendocrine TumorsEndocrine Reviews, 2004
- Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic systemAnnals of Oncology, 2004
- Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal TumoursNeuroendocrinology, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000